The impacts of minimally invasive surgery on intermediate- or high-risk cervical cancer patients received adjuvant radiotherapy

被引:0
|
作者
Qiying Zhang
Zi Liu
Yali Wang
Jing Zhang
Wen Li
Tao Wang
Juan Wang
Fan Shi
Jin Su
机构
[1] The First Affiliated Hospital of Xi’an Jiaotong University,Department of Radiation Oncology
[2] The Second Affiliated Hospital of Xi’an Jiao Tong University,Department of Radiation Oncology
关键词
Cervical cancer; Minimally invasive surgery; Open surgery; Radiotherapy; Chemotherapy;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [41] Adjuvant radiochemotherapy in patients with locally advanced high-risk cervical cancer
    Heinzelmann, F.
    Henke, G.
    von Grafenstein, M.
    Weidner, N.
    Paulsen, F.
    Staebler, A.
    Brucker, S.
    Bamberg, M.
    Weinmann, M.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2012, 188 (07) : 568 - 575
  • [42] Acute toxicity of curative radiotherapy for intermediate- and high-risk localised prostate cancer in the EORTC trial 22991
    Matzinger, O.
    Duclos, F.
    van den Bergh, A.
    Carrie, C.
    Villa, S.
    Kitsios, P.
    Poortmans, P.
    Sundar, S.
    van der Steen-Banasik, E. M.
    Gulyban, A.
    Collette, L.
    Bolla, M.
    EUROPEAN JOURNAL OF CANCER, 2009, 45 (16) : 2825 - 2834
  • [43] Adjuvant pelvic radiotherapy for pathological high-risk muscle-invasive bladder cancer
    Sargos, P.
    Latorzeff, I.
    Flechon, A.
    Roubaud, G.
    Brouste, V.
    Gaston, R.
    Piechaud, T.
    Orre, M.
    RADIOTHERAPY AND ONCOLOGY, 2016, 119 : S647 - S647
  • [44] Adjuvant radiotherapy for pathological high-risk muscle invasive bladder cancer: time to reconsider?
    Sargos, Paul
    Baumann, Brian C.
    Eapen, Libni J.
    Bahl, Amit
    Murthy, Vedang
    Roubaud, Guilhem
    Orre, Mathieu
    Efstathiou, Jason A.
    Shariat, Shahrokh
    Larre, Stephane
    Richaud, Pierre
    Christodouleas, John P.
    TRANSLATIONAL ANDROLOGY AND UROLOGY, 2016, 5 (05) : 702 - 710
  • [45] The role of proton beam therapy for patients with intermediate- and high-risk prostate cancer.
    Arimura, Takeshi
    Kondo, Naoaki
    Matsukawa, Kyoko
    Wada, Kiyotaka
    Kitano, Ikumi
    Chuman, Ikuko
    Nagata, Ichiro
    Ogino, Takashi
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [46] Adjuvant simultaneous integrated boost IMRT for patients with intermediate- and high-risk head and neck cancer: Outcome, toxicities and patterns of failure
    Stromberger, Carmen
    Jann, David
    Becker, Eva-Tessina
    Raguse, Jan-Dirk
    Tinhofer, Ingeborg
    Marnitz, Simone
    Budach, Volker
    ORAL ONCOLOGY, 2014, 50 (11) : 1114 - 1121
  • [47] FREEDOM FROM ANDROGEN DEPRIVATION AND RADIOTHERAPY THERAPY AFTER UPFRONT MINIMALLY INVASIVE SURGERY FOR HIGH-RISK PROSTATE CANCER
    Vives, Pol Servian
    Patel, Amit
    Eldred-Evans, David
    Cahill, Declan
    Brown, Christian
    Challacombe, Ben
    Winkler, Mathias
    JOURNAL OF UROLOGY, 2017, 197 (04): : E718 - E718
  • [48] Hypofractionated radiotherapy versus conventional radiotherapy in patients with intermediate- to high-risk localized prostate cancer: a meta-analysis of randomized controlled trials
    Wei Guo
    Yun-Chuan Sun
    Jian-Qiang Bi
    Xin-Ying He
    Li Xiao
    BMC Cancer, 19
  • [49] Hypofractionated radiotherapy versus conventional radiotherapy in patients with intermediate- to high-risk localized prostate cancer: a meta-analysis of randomized controlled trials
    Guo, Wei
    Sun, Yun-Chuan
    Bi, Jian-Qiang
    He, Xin-Ying
    Xiao, Li
    BMC CANCER, 2019, 19 (01)
  • [50] Clinical Use of Ultrasensitive Cardiac Troponin I Assay in Intermediate- and High-Risk Surgery Patients
    Borges, Flavia Kessler
    Furtado, Mariana Vargas
    Webber Rossini, Ana Paula
    Bertoluci, Carolina
    Gonzalez, Vinicius Leite
    Bertoldi, Eduardo Gehling
    Pezzali, Luiza Guazzeli
    Machado, Daniel Luft
    Grutcki, Denis Maltz
    Rech, Leandro Gazziero
    Magalhaes, Mariana
    Polanczyk, Carisi Anne
    DISEASE MARKERS, 2013, 2013 : 945 - 953